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Oral administration can induce unresponsiveness to pro-tein antigens.1 We have already shown that oral deliv-ery of donor splenocytes induces prolonged survival ofallogeneic or xenogeneic grafts when delivered with a
nondepleting anti-CD4 monoclonal antibody (anti-CD4).2,3
Intravenous injection of a single major histocompatibility complex
(MHC) molecule has been shown to induce prolongation of fully
MHC-mismatched grafts.4 This phenomenon can be explained by
the linked suppression,4,5 in which tolerance to strain (AxB)F1 is
also established when recipients become tolerant to strain A.
Therefore, we have examined whether a single donor MHC anti-
gen or soluble ovalbumin (OVA) could induce survival of fully
MHC-mismatched cardiac grafts when delivered into the alimen-
tary tract with anti-CD4.
Mice (8-12 weeks of age) were purchased from Sankyo (Tokyo,
Japan) and housed in conventional facilities of the Biomedical
Services Unit, Teikyo Hospital, Tokyo, and used in accordance
with the Animal Care Guidelines of Teikyo University. Mouse
hearts were transplanted into the abdomen of a recipient by means
of a microsurgical technique.2 Naive CBA (H2k) mice fully reject-
ed allogeneic C57BL/10 (H2b) cardiac grafts, with 8 days of medi-
an survival time (MST; Table 1). When CBA mice were fed with 1
× 107 C57BL/10 splenocytes (day –7) combined with intraperi-
toneal injection of a nondepleting anti-CD4 (days –8 and –7, 200
µg per dose, YTS 1772; hybridoma kindly provided by H.
Waldmann, Oxford, United Kingdom), the majority of grafts sur-
vived indefinitely (MST >100 days, Table 1), whereas mice pre-
treated orally with splenocytes alone or with anti-CD4 alone
rejected their grafts (MST = 8 and 7.5 days in Table 1). Intravenous
injection of C57BL/10 splenocytes combined with the anti-CD4
was less effective (MST = 15 days, data not shown), suggesting
that alloantigen delivery though the alimentary tract is essential to
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induce graft survival. Furthermore, when splenocytes from CBK
mice (an MHC class I, Kb, transgenic strain [H2k+Kb] in the con-
text of CBA4) were used for oral pretreatment in combination with
anti-CD4, all C57BL/10 grafts survived for more than 100 days
(Table 1). Therefore, oral exposure to a single donor alloantigen Kb
was sufficient to induce unresponsiveness to a fully allogeneic
C57BL/10 (H2b: Kb+Db+Lb+IAb) cardiac graft, which can be
explained by the linked suppression.4,5 On the other hand, we have
already shown that orally delivered cells are degraded and that
alloantigens may be presented on MHC molecules of the recipient
(ie, indirect allorecognition).2 The direct antigen recognition, in
which recipient T cells directly recognize MHC molecules on
donor cells, mainly generates acute rejection of a fully MHC-
mismatched graft. Taken together, these findings suggest that the
linked suppression through the indirect pathway is involved in sur-
vival of cardiac allografts in this model. Therefore, we speculated
that not only an MHC molecule but also a foreign protein antigen
can induce graft prolongation when delivered orally with anti-CD4
and presented at the time of transplantation. In an attempt to con-
firm this hypothesis, we fed CBA mice with 50 mg of OVA (day
–7) in the presence of anti-CD4 (days –8 and –7). All C57BL/10
grafts survived for more than 50 days when 50 mg of OVA was
again fed at the time of transplantation (MST >100 days, Table 1).
By contrast, mice only receiving OVA at the time of pretreatment
rejected their grafts within 50 days (MST = 24 days, Table 1),
demonstrating that a foreign peptide can induce unresponsiveness
to MHC molecules when pretreated orally with anti-CD4 and pre-
sented at the same time of transplantation.
In this study we can clearly demonstrate that importance of the
alimentary tract to induce unresponsiveness against fully allogene-
ic grafts with an MHC molecule or a foreign peptide in combina-
tion with nondepleting anti-CD4. This observation will be able to
apply clinical manipulation to induce operational tolerance against
allogeneic cardiac grafts.1 Recipients pretreated with oral adminis-
tration of a common MHC antigen in the presence of anti-CD4
may be tolerant to an allogeneic organ sharing the MHC antigen,
even if the other MHC antigens are mismatched.2 A recipient pre-
treated with oral administration of a foreign antigen in combina-
tion with anti-CD4 may accept any allogeneic organs when the for-
eign antigen coexists at the time of transplantation.
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TABLE 1. Indefinite survival of fully allogeneic C57BL/10 (H2b) cardiac grafts in CBA (H2k) mice treated with oral adminis-
tration and anti-CD4
Group Oral administration Anti-CD4* No. Graft survival (d) MST (d) P value†
1 None None 8 7, 7, 8, 8, 8, 8, 8, 9 8
2 None Day –8 and –7 8 7, 7, 7, 7, 8, 8, 8, 12 7.5 vs 1: NS
3 Day –7 (C57BL/10) None 7 7, 7, 7, 8, 8, 10, 16 8 vs 1: NS
4 Day –7 (C57BL/10) Day –8 and –7 8 40, 67, >100 ×6 >100 vs 1, 2, 3: <.01
5 Day –7 (CBK‡) Day –8 and –7 7 >100 × 7 >100 vs 1, 2, 3: <.01
6 Day –7 (OVA§) Day –8 and –7 7 15, 18, 20, 24, 30, 36, 50 24 vs 1, 2, 3: <.01
7 Day –7 and 0 (OVA) Day –8 and –7 9 52, 56, 70, 84, >100 ×5 >100 vs 1, 2, 3, 6: <.01
NS, Not significant.
*Anti-CD4, intraperitoneal injection of nondepleting anti-CD4 monoclonal antibody (YTS177, 200 µg per dose).
†Mann-Whitney U test versus group 1.
‡CBK, 1 × 107 CBK (H2k + Kb) splenocytes.
§Ovalbumin, 50 mg.
